Pelican Integrates Copy Trading Solution into USG UK Platforms

Social copy trading solutions provider Pelican Trading announced this Tuesday that it has partnered with USG UK, in which the former will integrate its into the latter’s range of trading platforms.
Pelican Trading is a white label provider for brokers. The company’s broker-neutral solution is able to connect directly with brokers. It integrates trading execution and communication into a central network for traders.

Under the partnership announced today, USG UK will be able to provide its client base with the features offered by Pelican’s copy-trading technology and social interface.

Mike Read, co-founder and CEO of Pelican Trading
Commenting on the partnership, Pelican Trading Co-Founder and CEO, Mike Read said in the statement: “Pelican continues to work with the best-known brokers in the FX sector, to provide our innovative copy trading solution to enhance their client’s experience. We are very pleased to announce our latest partnership with USG UK, and look forward to integrating our technology into their trading platform portfolio.”
Pelican Trading expands technology reach
In recent months, the social copy trading solutions provider has been announcing a number of market partnerships similar to the one announced today. As , Pelican Trading integrated its social copy trading technology in Advanced Markets’ trading platforms to expand its technology reach to a wider audience.
Towards , IS Prime also integrated Pelican Trading’s trading technology into its trading platform, allowing the liquidity provider to offer an expanded range of tools which form part of the Prime of Prime’s solution to help drive volumes and customer engagement.
USG moves headquarters to London
USG UK is the United Kingdom operations of the Union Standard International Group Holdings. Today’s announcement comes less than a month after the Group announced it would be out of Australia and into the UK, following Union Standard International Group PTY (USGFX) .

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *